- Home
- ISRG vs TMO Comparison
ISRG vs TMO Comparison
Compare ISRG & TMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ISRG
- TMO
- Stock Information
- Founded
- ISRG 1995
- TMO 1956
- Country
- ISRG United States
- TMO United States
- Employees
- ISRG N/A
- TMO N/A
- Industry
- ISRG Medical/Dental Instruments
- TMO Industrial Machinery/Components
- Sector
- ISRG Health Care
- TMO Industrials
- Exchange
- ISRG Nasdaq
- TMO Nasdaq
- Market Cap
- ISRG 167.4B
- TMO 175.3B
- IPO Year
- ISRG 2000
- TMO N/A
- Fundamental
- Price
- ISRG $441.16
- TMO $539.30
- Analyst Decision
- ISRG Buy
- TMO Buy
- Analyst Count
- ISRG 16
- TMO 15
- Target Price
- ISRG $595.87
- TMO $584.79
- AVG Volume (30 Days)
- ISRG 2.4M
- TMO 2.6M
- Earning Date
- ISRG 10-21-2025
- TMO 10-22-2025
- Dividend Yield
- ISRG N/A
- TMO 0.32%
- EPS Growth
- ISRG 23.20
- TMO 7.24
- EPS
- ISRG 7.17
- TMO 17.30
- Revenue
- ISRG $9,145,000,000.00
- TMO $43,212,000,000.00
- Revenue This Year
- ISRG $19.57
- TMO $3.54
- Revenue Next Year
- ISRG $14.45
- TMO $4.83
- P/E Ratio
- ISRG $61.51
- TMO $31.18
- Revenue Growth
- ISRG 20.77
- TMO 2.04
- 52 Week Low
- ISRG $425.00
- TMO $385.46
- 52 Week High
- ISRG $616.00
- TMO $610.97
- Technical
- Relative Strength Index (RSI)
- ISRG 43.16
- TMO 69.85
- Support Level
- ISRG $430.38
- TMO $456.67
- Resistance Level
- ISRG $459.81
- TMO $487.99
- Average True Range (ATR)
- ISRG 9.40
- TMO 14.59
- MACD
- ISRG 2.11
- TMO 7.51
- Stochastic Oscillator
- ISRG 36.03
- TMO 90.48
About ISRG Intuitive Surgical Inc.
Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed more than 9,500 da Vinci systems in hospitals worldwide, with more than 5,500 installations in the US and a growing number in emerging markets.
About TMO Thermo Fisher Scientific Inc
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year-end 2024 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (the remainder).